The selectively targeting JAK‐STAT by exogenously synthesized or intrinsic small molecule inhibitors could result in the apoptosis alternation both in normal cells and in tumor cells (O'Sullivan et al., 2007; Schindler, 1999). The gene discussed is SOAT1; the disease is neoplasm.